Spanish scientists identify a new treatment strategy against a very aggressive subtype of breast cancer Published on 19/10/2022 HER2+ breast cancer, diagnosed in 7,000 new cases in 2022, is a very aggressive subtype of poor prognosis because most patients develop drug resistance
MD Anderson Madrid – Hospiten inaugurates their Phase I Clinical Trials Unit, one of the largest in Spain and Europe dedicated to the first phase of research Published on 03/11/2021 Advised directly from Houston, the unit will focus on research into the most promising cancer drugs in clinical development worldwide. It is estimated that more than 40 clinical studies in phase I will be investigated simultaneously
MD Anderson Madrid – Hospiten and El Economista join Movember to offer health advice for men over 40 Published on 14/11/2019 This year the MD Anderson Cancer Center Madrid – Hospiten has again joined in with the Movember movement, an initiative now over ten years old that seeks to boost men’s healthcare during November.
The Spanish Cancer Association (AECC) funds a research project in endometrial cancer in which MD Anderson Cancer Center Foundation Spain is participating Published on 28/09/2018 The Spanish Cancer Association (AECC) has granted aid worth one million euros in five years to an advanced endometrial cancer research project involving five cooperative clinical a...
MD Anderson Cancer Center Madrid – Hospiten organizes a preceptorship with a focus on the current challenges in neuroendocrine tumors Published on 26/09/2018 Last Thursday, September 20 and Friday, September 21 MD Anderson Cancer Center Madrid – Hospiten, in collaboration with Pfizer, organized a preceptorship focused on the clinical management of...